Controlled-release dosage forms of azithromycin
US7108865B2 · kind B2 · utility
17Cited by
17References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 2001 |
| Grant date | Sep 19, 2006 |
| Priority date | — |
| Expiry date | Mar 9, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A controlled-release dosage form of azithromycin having an improved side effect profile; a process for preparing the dosage form; and a method of treating a microbial infection, comprising administering azithromycin in such a controlled-release dosage form to a mammal, including a human patient, in need of such treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.